L-glutamine (Endari)
Jump to navigation
Jump to search
Pharmaceutical grade L-glutamine
Diseases for which it is used
History of changes in FDA indication
- 2017-07-07: Approved for patients age five years and older with sickle cell disease to reduce severe complications associated with the blood disorder.
Also known as
- Brand name: Endari